Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Espey Mfg & Electronics Corp
ESP
$192M
| $2.88M | 0.01% |
113,800
+2,400
| +2% | +$62.5K |
|
|
OMED
1977
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $2.88M | 0.01% |
+251,600
| New | +$2.93M |
|
1978
Digi International
DGII
$3.23B
| $2.87M | 0.01% |
252,000
+30,300
| +14% | +$344K |
|
1979
Insmed
INSM
$27B
| $2.87M | 0.01% |
197,700
+48,400
| +32% | +$606K |
|
|
ARRY
1980
DELISTED
Array Biopharma Inc
ARRY
| $2.87M | 0.01% |
424,452
+407,000
| +2,332% | +$1.57M |
|
|
KW
1981
DELISTED
Kennedy-Wilson Holdings
KW
| $2.86M | 0.01% |
127,000
-247,100
| -66% | -$5.25M |
|
|
MIK
1982
DELISTED
Michaels Stores, Inc
MIK
| $2.86M | 0.01% |
118,400
+59,500
| +101% | +$1.52M |
|
1983
Citizens & Northern Corp
CZNC
$466M
| $2.85M | 0.01% |
129,700
-21,500
| -14% | -$456K |
|
1984
Genesis Energy
GEL
$1.93B
| $2.85M | 0.01% |
75,000
+54,300
| +262% | +$1.99M |
|
1985
James Hardie Industries
JHX
$18B
| $2.85M | 0.01% |
180,900
+15,600
| +9% | +$254K |
|
1986
German American Bancorp
GABC
$1.93B
| $2.84M | 0.01% |
109,350
-5,850
| -5% | -$138K |
|
|
EVRI
1987
DELISTED
Everi Holdings
EVRI
| $2.83M | 0.01% |
1,146,200
+381,700
| +50% | +$759K |
|
|
WMGI
1988
DELISTED
Wright Medical Group Inc
WMGI
| $2.83M | 0.01% |
115,207
-20,904
| -15% | -$481K |
|
|
REGI
1989
DELISTED
Renewable Energy Group, Inc.
REGI
| $2.82M | 0.01% |
332,561
+108,334
| +48% | +$958K |
|
1990
United-Guardian
UG
$32.8M
| $2.81M | 0.01% |
191,900
+10,800
| +6% | +$163K |
|
1991
NatWest
NWG
$76B
| $2.81M | 0.01% |
560,300
-1,118,484
| -67% | -$5.97M |
|
|
NETI
1992
DELISTED
Eneti Inc.
NETI
| $2.81M | 0.01% |
87,243
+17,872
| +26% | +$556K |
|
|
ORBC
1993
DELISTED
ORBCOMM, Inc.
ORBC
| $2.81M | 0.01% |
+273,700
| New | +$2.8M |
|
|
SEAC
1994
DELISTED
Seachange International Inc
SEAC
| $2.8M | ﹤0.01% |
46,756
+9,470
| +25% | +$589K |
|
|
ICON
1995
DELISTED
Iconix Brand Group, Inc.
ICON
| $2.8M | ﹤0.01% |
+34,438
| New | +$2.68M |
|
|
TTPH
1996
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $2.79M | ﹤0.01% |
36,450
-2,790
| -7% | -$224K |
|
1997
AllianceBernstein
AB
$3.41B
| $2.79M | ﹤0.01% |
122,400
+99,900
| +444% | +$2.26M |
|
|
MRLN
1998
DELISTED
Marlin Business Services Corp
MRLN
| $2.79M | ﹤0.01% |
143,800
+35,600
| +33% | +$645K |
|
1999
Shore Bancshares
SHBI
$800M
| $2.78M | ﹤0.01% |
236,100
+32,100
| +16% | +$376K |
|
|
OSG
2000
Octave Specialty Group
OSG
$221M
| $2.77M | ﹤0.01% |
150,800
+85,566
| +131% | +$1.54M |
|
Similar funds
Jim Simons's Q3 2016 Portfolio in Review
As of Q3 2016, Jim Simons held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $1.92B of net new capital in Q3 2016, opening 414 new positions and adding to 1,834 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Jim Simons's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Jim Simons added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Jim Simons's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Jim Simons fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Jim Simons's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Jim Simons opened 414 new positions and closed 416 in Q3 2016.
- Jim Simons's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.